BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:PCOS Externally-Led Patient-Focused Drug Development Meeting (
 PCOS EL-PFDD Meeting) Presented by PCOS Challenge: The National Polycysti
 c Ovary Syndrome Association\n\n&nbsp\;\n\nAbout Polycystic Ovary Syndrom
 e (PCOS)\n\nPCOS is a serious genetic\, hormone\, metabolic\, and reprodu
 ctive disorder that affects up to 15% of women. PCOS can lead to lifelong
  complications\, infertility\, anxiety\, depression and other psychosocia
 l disorders\, obesity\, severe hair and skin issues\, endometrial cancer\
 , type 2 diabetes\, cardiovascular disease\, stroke\, nonalcoholic fatty 
 liver disease\, and other major conditions. Despite the significant healt
 h impact and $15 billion annual economic burden\, there have never been a
 ny FDA-approved treatments specifically for PCOS.\n\n&nbsp\;\n\nAbout the
  Meeting - Accelerating New Treatments for PCOS\n\nThe PCOS EL-PFDD Meeti
 ng is a listening session for the FDA\, clinicians\, researchers\, and pr
 oduct developers to hear directly from PCOS patients about their lived ex
 perience with PCOS and their perspectives on current and future treatment
 s and clinical trials. The insights from this meeting will help guide the
  FDA's decision-making processes both in drug development and marketing a
 pplication reviews.\n\n&nbsp\;\n\nBenefits for Patients of Attending\n\nP
 articipating in this meeting grants patients the unprecedented opportunit
 y to influence the development of PCOS-focused treatments and diagnostics
 . Benefits include:\n\n\n Directly informing stakeholders about the daily
  impacts and health effects of living with PCOS.\n Sharing perspectives o
 n the effectiveness of existing treatment and management options.\n Highl
 ighting patients' unmet needs and priorities for new treatments.\n\n&nbsp
 \;\n\nBenefits for Pharma/Industry Representatives Attending\n\nFor indus
 try stakeholders\, attending this meeting is a strategic move toward pati
 ent-centered innovation. Benefits encompass:\n\n\n Gaining an in-depth un
 derstanding of patients' experiences\, symptom burden\, and treatment his
 tory.\n Learning the multiple factors influencing patients' treatment cho
 ices and trial participation.\n Identifying unmet needs in PCOS care to d
 rive more effective drug development.\n Obtaining insights to design pati
 ent-centered clinical trials tailored to meet the needs and priorities of
  the PCOS community.\n\n&nbsp\;\n\nAdmission: Free\n\n&nbsp\;\n\nSponsor 
 opportunities are available.\n\nFor more information and to register\, vi
 sit the PCOS PFDD Website\n
DTEND:20231103T143000
DTSTAMP:20260514T153516Z
DTSTART:20231103T100000
LOCATION:Samuel Riggs IV Alumni Center\, 7801\, Alumni Drive\, Prince Geor
 ge's County\, 20742\,
SEQUENCE:0
SUMMARY:PCOS Externally-Led Patient-Focused Drug Development Meeting (PCOS
  EL-PFDD Meeting) Presented by PCOS Challenge: The National Polycystic Ov
 ary Synd...
UID:5841084d-c2c8-455e-9e8b-b97108fd523f
END:VEVENT
END:VCALENDAR